Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ubr7 Inhibitors

Ubr7 inhibitors constitute a class of chemical compounds specifically designed for research purposes, targeting the Ubiquitin protein ligase E3 component n-recognin 7 (Ubr7). Ubr7 is part of the ubiquitin-proteasome system, a critical pathway in cellular regulation that involves tagging unwanted or damaged proteins with ubiquitin for degradation. As an E3 ubiquitin ligase, Ubr7 plays a pivotal role in this process by recognizing specific protein substrates and facilitating their ubiquitination, which marks them for degradation by the proteasome. The mechanism of action of Ubr7 inhibitors can be either direct or indirect. Direct inhibitors typically function by binding to the active site of Ubr7, thereby interfering with its ability to interact with its substrates or with the E2 ubiquitin-conjugating enzyme. This interaction is crucial for the transfer of ubiquitin from the E2 enzyme to the substrate protein. By blocking this interaction, direct inhibitors prevent the ubiquitination of substrate proteins, thereby impeding their subsequent degradation.

Indirect inhibitors, on the other hand, may not bind to Ubr7 directly. Instead, they might influence the protein's activity by altering its expression levels, post-translational modifications, or interaction with other proteins that regulate its function. For example, compounds that affect the upstream signaling pathways that regulate Ubr7 expression or activation can indirectly modulate its activity. Similarly, molecules that alter the cellular localization of Ubr7 or its availability can also serve as indirect inhibitors. In research settings, Ubr7 inhibitors are valuable tools for investigating the role of ubiquitination in cellular processes. By modulating Ubr7 activity, researchers can study its involvement in the regulation of protein turnover, signal transduction, and cellular homeostasis. These studies are crucial for understanding the mechanisms of protein degradation and the broader implications of ubiquitin-mediated regulation in cellular physiology.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

A proteasome inhibitor that could lead to the accumulation of ubiquitinated proteins, potentially affecting Ubr7 substrate availability.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Another proteasome inhibitor, which might indirectly influence Ubr7 activity by altering proteasome-mediated degradation pathways.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

An inhibitor of ubiquitin-activating enzyme E1, potentially impacting the upstream steps of ubiquitination and indirectly affecting Ubr7 function.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$165.00
$575.00
60
(2)

A specific inhibitor of the proteasome, which could lead to altered protein degradation dynamics, indirectly influencing Ubr7's role.

MLN 4924

905579-51-3sc-484814
1 mg
$280.00
1
(0)

An inhibitor of NEDD8-activating enzyme, affecting neddylation and potentially altering the activity of Ubr7.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Modulates the ubiquitin ligase activity of the cereblon complex, which could have downstream effects on Ubr7-related pathways.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$56.00
$212.00
$764.00
24
(1)

Disrupts the interaction between p53 and MDM2, potentially affecting ubiquitin ligase activity and indirectly influencing Ubr7.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Known to inhibit autophagy, which could indirectly affect ubiquitin-related pathways and Ubr7 activity.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$66.00
$153.00
16
(2)

An Hsp90 inhibitor, potentially affecting the stability of proteins involved in ubiquitination and indirectly influencing Ubr7.

Withaferin A

5119-48-2sc-200381
sc-200381A
sc-200381B
sc-200381C
1 mg
10 mg
100 mg
1 g
$127.00
$572.00
$4090.00
$20104.00
20
(1)

Known to inhibit the proteasomal activity, potentially impacting the ubiquitin-proteasome system and Ubr7 function.